National Bank of Canada’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66M | Buy |
434,868
+400,881
| +1,180% | +$60.8M | 0.06% | 214 |
|
|
2025
Q1 | $5.12M | Buy |
33,987
+10,132
| +42% | +$1.53M | 0.01% | 746 |
|
|
2024
Q4 | $4.4M | Buy |
23,855
+2,639
| +12% | +$486K | ﹤0.01% | 794 |
|
|
2024
Q3 | $4.18M | Buy |
21,216
+6,627
| +45% | +$1.31M | ﹤0.01% | 753 |
|
|
2024
Q2 | $2.96M | Sell |
14,589
-28,089
| -66% | -$5.71M | ﹤0.01% | 770 |
|
|
2024
Q1 | $9.74M | Sell |
42,678
-61,096
| -59% | -$13.9M | 0.01% | 523 |
|
|
2023
Q4 | $23.4M | Sell |
103,774
-18,681
| -15% | -$4.22M | 0.04% | 305 |
|
|
2023
Q3 | $23.5M | Buy |
122,455
+41,662
| +52% | +$8M | 0.04% | 300 |
|
|
2023
Q2 | $16.9M | Sell |
80,793
-7,859
| -9% | -$1.64M | 0.03% | 350 |
|
|
2023
Q1 | $17.8M | Sell |
88,652
-13,711
| -13% | -$2.75M | 0.04% | 256 |
|
|
2022
Q4 | $22.3M | Buy |
102,363
+51,321
| +101% | +$11.2M | 0.06% | 242 |
|
|
2022
Q3 | $10.4M | Buy |
51,042
+3,070
| +6% | +$626K | 0.06% | 320 |
|
|
2022
Q2 | $10.5M | Buy |
47,972
+1,487
| +3% | +$325K | 0.05% | 303 |
|
|
2022
Q1 | $13.8M | Buy |
46,485
+44,519
| +2,264% | +$13.2M | 0.04% | 292 |
|
|
2021
Q4 | $688K | Buy |
+1,966
| New | +$688K | ﹤0.01% | 1004 |
|